Chinese logistics service provider Dekun has raised 500 million yuan ($70 million) led by China’s BOCG Investment while Atom Bioscience has secured $30 million in a Series B round led by Sequoia Capital China and Hong Kong-listed Livzon Pharm.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
